Skip to main content
SpringerLink
Log in

Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation

  • Nephrology – Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, Rougier JP et al. (2011) Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol: CJASN 6(7):1609–1616. PubMed PMID: 21700823. Epub 2011/06/28. eng

  2. Dillon JJ, Hladunewich M, Haley WE, Reich HN, Cattran DC, Fervenza FC (2012) Rituximab therapy for Type I membranoproliferative glomerulonephritis. Clin Nephrol 77(4):290–295. PubMed PMID: 22445472. Epub 2012/03/27. eng

  3. Perez-Saez MJ, Toledo K, Navarro MD, Lopez-Andreu M, Redondo MD, Ortega R et al. (2011) Recurrent membranoproliferative glomerulonephritis after second renal graft treated with plasmapheresis and rituximab. Transplant Proc 43(10):4005–4009. PubMed PMID: 22172889. Epub 2011/12/17. eng

  4. Gurcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR (2009) A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 9(1):10–25. PubMed PMID: 19000786. Epub 2008/11/13. eng

  5. Cravedi P, Ruggenenti P, Sghirlanzoni MC, Remuzzi G (2007) Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol: CJASN 2(5):932–937. PubMed PMID: 17702725. Epub 2007/08/19. eng

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Renal Transplant Service, Hospital das Clínicas, Instituto Central, University of São Paulo School of Medicine, sala 7036, Av. Dr. Enéas de Carvalho Aguiar 255, São Paulo, SP, 05403-000, Brazil

    Igor Denizarde Bacelar Marques, Daísa Ribeiro David, William Carlos Nahas & Elias David-Neto

  2. Nephrology Division, Hospital Sírio-Libanes, São Paulo, Brazil

    Igor Denizarde Bacelar Marques, William Carlos Nahas & Elias David-Neto

  3. Pathology Division, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil

    Daísa Ribeiro David

  4. Nephrology Division, University of São Paulo School of Medicine, São Paulo, Brazil

    Janaina Ramalho

Authors
  1. Igor Denizarde Bacelar Marques
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janaina Ramalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daísa Ribeiro David
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William Carlos Nahas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elias David-Neto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Igor Denizarde Bacelar Marques.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marques, I.D.B., Ramalho, J., David, D.R. et al. Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation. Int Urol Nephrol 46, 2053–2054 (2014). https://doi.org/10.1007/s11255-014-0792-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0792-0

Keywords

Search

Navigation